# FDA Warning Letter: AstraZeneca Pharmaceuticals LP
> 2023-08-15 · The Office of Prescription Drug Promotion (OPDP) · `730e5c406ade6e11`
## Letter
- **Company:** AstraZeneca Pharmaceuticals LP
- **Posted Date:** 2023-08-15
- **Letter Issue Date:** 2023-08-04
- **Issuing Office:** The Office of Prescription Drug Promotion (OPDP)
## Subject
False & Misleading Claims/Misbranded
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*